The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Clinical Next-Generation Sequencing Market Research Report 2025
Synopsis
Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.
The global Clinical Next-Generation Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Clinical Next-Generation Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clinical Next-Generation Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Clinical Next-Generation Sequencing in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Clinical Next-Generation Sequencing include Thermo Fisher Scientific, PerkinElmer, Illumina, Beckman Coulter, GATC Biotech and Qiagen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Next-Generation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Next-Generation Sequencing.
Report Scope
The Clinical Next-Generation Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Next-Generation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Next-Generation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
Segment by Type
Targeted Sequencing
Exome Sequencing
Others
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Next-Generation Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.
The global Clinical Next-Generation Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Clinical Next-Generation Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Clinical Next-Generation Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Clinical Next-Generation Sequencing in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Clinical Next-Generation Sequencing include Thermo Fisher Scientific, PerkinElmer, Illumina, Beckman Coulter, GATC Biotech and Qiagen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Clinical Next-Generation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Next-Generation Sequencing.
Report Scope
The Clinical Next-Generation Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Clinical Next-Generation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Next-Generation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
Segment by Type
Targeted Sequencing
Exome Sequencing
Others
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Next-Generation Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Targeted Sequencing
1.2.3 Exome Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Clinical Next-Generation Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Next-Generation Sequencing Market Perspective (2019-2030)
2.2 Clinical Next-Generation Sequencing Growth Trends by Region
2.2.1 Global Clinical Next-Generation Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Clinical Next-Generation Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Clinical Next-Generation Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Clinical Next-Generation Sequencing Market Dynamics
2.3.1 Clinical Next-Generation Sequencing Industry Trends
2.3.2 Clinical Next-Generation Sequencing Market Drivers
2.3.3 Clinical Next-Generation Sequencing Market Challenges
2.3.4 Clinical Next-Generation Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Next-Generation Sequencing Players by Revenue
3.1.1 Global Top Clinical Next-Generation Sequencing Players by Revenue (2019-2024)
3.1.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Clinical Next-Generation Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Next-Generation Sequencing Revenue
3.4 Global Clinical Next-Generation Sequencing Market Concentration Ratio
3.4.1 Global Clinical Next-Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Next-Generation Sequencing Revenue in 2023
3.5 Clinical Next-Generation Sequencing Key Players Head office and Area Served
3.6 Key Players Clinical Next-Generation Sequencing Product Solution and Service
3.7 Date of Enter into Clinical Next-Generation Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Next-Generation Sequencing Breakdown Data by Type
4.1 Global Clinical Next-Generation Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Type (2025-2030)
5 Clinical Next-Generation Sequencing Breakdown Data by Application
5.1 Global Clinical Next-Generation Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Clinical Next-Generation Sequencing Market Size (2019-2030)
6.2 North America Clinical Next-Generation Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Clinical Next-Generation Sequencing Market Size by Country (2019-2024)
6.4 North America Clinical Next-Generation Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Next-Generation Sequencing Market Size (2019-2030)
7.2 Europe Clinical Next-Generation Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Clinical Next-Generation Sequencing Market Size by Country (2019-2024)
7.4 Europe Clinical Next-Generation Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Next-Generation Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Clinical Next-Generation Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Next-Generation Sequencing Market Size (2019-2030)
9.2 Latin America Clinical Next-Generation Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Clinical Next-Generation Sequencing Market Size by Country (2019-2024)
9.4 Latin America Clinical Next-Generation Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Next-Generation Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Clinical Next-Generation Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Clinical Next-Generation Sequencing Introduction
11.2.4 PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2019-2024)
11.2.5 PerkinElmer Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Clinical Next-Generation Sequencing Introduction
11.3.4 Illumina Revenue in Clinical Next-Generation Sequencing Business (2019-2024)
11.3.5 Illumina Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Detail
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Clinical Next-Generation Sequencing Introduction
11.4.4 Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 GATC Biotech
11.5.1 GATC Biotech Company Detail
11.5.2 GATC Biotech Business Overview
11.5.3 GATC Biotech Clinical Next-Generation Sequencing Introduction
11.5.4 GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2019-2024)
11.5.5 GATC Biotech Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Detail
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Clinical Next-Generation Sequencing Introduction
11.6.4 Qiagen Revenue in Clinical Next-Generation Sequencing Business (2019-2024)
11.6.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Targeted Sequencing
Table 3. Key Players of Exome Sequencing
Table 4. Key Players of Others
Table 5. Global Clinical Next-Generation Sequencing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Clinical Next-Generation Sequencing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Clinical Next-Generation Sequencing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Clinical Next-Generation Sequencing Market Share by Region (2019-2024)
Table 9. Global Clinical Next-Generation Sequencing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Clinical Next-Generation Sequencing Market Share by Region (2025-2030)
Table 11. Clinical Next-Generation Sequencing Market Trends
Table 12. Clinical Next-Generation Sequencing Market Drivers
Table 13. Clinical Next-Generation Sequencing Market Challenges
Table 14. Clinical Next-Generation Sequencing Market Restraints
Table 15. Global Clinical Next-Generation Sequencing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Clinical Next-Generation Sequencing Market Share by Players (2019-2024)
Table 17. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next-Generation Sequencing as of 2023)
Table 18. Ranking of Global Top Clinical Next-Generation Sequencing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Clinical Next-Generation Sequencing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Clinical Next-Generation Sequencing Product Solution and Service
Table 22. Date of Enter into Clinical Next-Generation Sequencing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Clinical Next-Generation Sequencing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Clinical Next-Generation Sequencing Revenue Market Share by Type (2019-2024)
Table 26. Global Clinical Next-Generation Sequencing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Clinical Next-Generation Sequencing Revenue Market Share by Type (2025-2030)
Table 28. Global Clinical Next-Generation Sequencing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2019-2024)
Table 30. Global Clinical Next-Generation Sequencing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2025-2030)
Table 32. North America Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Clinical Next-Generation Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Clinical Next-Generation Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Clinical Next-Generation Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Clinical Next-Generation Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Clinical Next-Generation Sequencing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Clinical Next-Generation Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Clinical Next-Generation Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Detail
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Clinical Next-Generation Sequencing Product
Table 50. Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. PerkinElmer Company Detail
Table 53. PerkinElmer Business Overview
Table 54. PerkinElmer Clinical Next-Generation Sequencing Product
Table 55. PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 56. PerkinElmer Recent Development
Table 57. Illumina Company Detail
Table 58. Illumina Business Overview
Table 59. Illumina Clinical Next-Generation Sequencing Product
Table 60. Illumina Revenue in Clinical Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 61. Illumina Recent Development
Table 62. Beckman Coulter Company Detail
Table 63. Beckman Coulter Business Overview
Table 64. Beckman Coulter Clinical Next-Generation Sequencing Product
Table 65. Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 66. Beckman Coulter Recent Development
Table 67. GATC Biotech Company Detail
Table 68. GATC Biotech Business Overview
Table 69. GATC Biotech Clinical Next-Generation Sequencing Product
Table 70. GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 71. GATC Biotech Recent Development
Table 72. Qiagen Company Detail
Table 73. Qiagen Business Overview
Table 74. Qiagen Clinical Next-Generation Sequencing Product
Table 75. Qiagen Revenue in Clinical Next-Generation Sequencing Business (2019-2024) & (US$ Million)
Table 76. Qiagen Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Next-Generation Sequencing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Clinical Next-Generation Sequencing Market Share by Type: 2023 VS 2030
Figure 3. Targeted Sequencing Features
Figure 4. Exome Sequencing Features
Figure 5. Others Features
Figure 6. Global Clinical Next-Generation Sequencing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Clinical Next-Generation Sequencing Market Share by Application: 2023 VS 2030
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Biopharma Companies Case Studies
Figure 10. Academic and Research Organizations Case Studies
Figure 11. Others Case Studies
Figure 12. Clinical Next-Generation Sequencing Report Years Considered
Figure 13. Global Clinical Next-Generation Sequencing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Clinical Next-Generation Sequencing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Clinical Next-Generation Sequencing Market Share by Region: 2023 VS 2030
Figure 16. Global Clinical Next-Generation Sequencing Market Share by Players in 2023
Figure 17. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next-Generation Sequencing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Clinical Next-Generation Sequencing Revenue in 2023
Figure 19. North America Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Clinical Next-Generation Sequencing Market Share by Country (2019-2030)
Figure 21. United States Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Clinical Next-Generation Sequencing Market Share by Country (2019-2030)
Figure 25. Germany Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Clinical Next-Generation Sequencing Market Share by Region (2019-2030)
Figure 33. China Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Clinical Next-Generation Sequencing Market Share by Country (2019-2030)
Figure 41. Mexico Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Clinical Next-Generation Sequencing Market Share by Country (2019-2030)
Figure 45. Turkey Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Clinical Next-Generation Sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2019-2024)
Figure 48. PerkinElmer Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2019-2024)
Figure 49. Illumina Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2019-2024)
Figure 50. Beckman Coulter Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2019-2024)
Figure 51. GATC Biotech Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2019-2024)
Figure 52. Qiagen Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
